CHAMPIONS ONCOLOGY, INC. Cash Equivalents, at Carrying Value
CHAMPIONS ONCOLOGY, INC. (CSBR) had Cash Equivalents, at Carrying Value of $0 as of 2026-04-30, per its 10-K filed 2026-07-27.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-07-27
- 2026-04-30: Cash Equivalents, at Carrying Value $0.00.
- 2025-04-30: Cash Equivalents, at Carrying Value $0.00.
- 2024-04-30: Cash Equivalents, at Carrying Value $0.00.
- 2024-01-31: Cash Equivalents, at Carrying Value $2.90M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2026-04-30 | $0.00 10-K · filed 2026-07-27 |
| 2025-04-30 | $0.00 10-K · filed 2026-07-27 |
| 2024-04-30 | $0.00 10-K · filed 2025-07-23 |
| 2024-01-31 | $2.90M 10-Q · filed 2024-03-15 |
| 2023-10-31 | $3.60M 10-Q · filed 2023-12-13 |
| 2023-07-31 | $4.10M 10-Q · filed 2023-09-13 |
| 2023-04-30 | $0.00 10-K · filed 2024-07-19 |
| 2023-01-31 | $0.00 10-Q · filed 2023-03-16 |
| 2022-10-31 | $0.00 10-Q · filed 2022-12-13 |
| 2022-07-31 | $0.00 10-Q · filed 2022-09-12 |
| 2022-04-30 | $0.00 10-K · filed 2023-07-24 |
| 2022-01-31 | $0.00 10-Q · filed 2022-03-15 |
| 2021-10-31 | $0.00 10-Q · filed 2021-12-13 |
| 2021-07-31 | $0.00 10-Q · filed 2021-09-13 |
| 2021-04-30 | $0.00 10-K · filed 2022-07-22 |
| 2021-01-31 | $0.00 10-Q · filed 2021-03-15 |
| 2020-10-31 | $0.00 10-Q · filed 2020-12-14 |
| 2020-07-31 | $0.00 10-Q · filed 2020-09-14 |
| 2020-04-30 | $0.00 10-K · filed 2021-07-26 |
| 2019-04-30 | $0.00 10-K · filed 2020-07-28 |
| 2018-07-31 | $0.00 10-Q · filed 2018-09-14 |
| 2018-04-30 | $0.00 10-Q · filed 2018-09-14 |
| 2016-01-31 | $3.30M 10-Q · filed 2016-03-16 |
| 2015-10-31 | $4.20M 10-Q · filed 2015-12-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |